Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€81.00
24.06.23
€100.00
31.12.25
-12.91%
12:45

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€85.44
24.06.23
€100.00
31.07.25
-10.11%
07.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€1.19
24.06.23
€3.00
31.03.26
-21.31%
06.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€38.49
24.06.23
€50.00
31.03.26
-42.32%
12:17

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€7.14
24.06.23
€9.00
30.11.25
84.45%
14:25

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€105.00
24.06.23
€200.00
30.04.26
44.38%
09:24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 80%
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€214.90
24.06.23
€380.00
31.05.26
-6.33%
14:05

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€62.00
24.06.23
€90.00
31.03.26
-64.84%
07.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€44.20
24.06.23
€60.00
31.12.25
-72.70%
09:21

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€10.60
24.06.23
€20.00
31.12.25
-21.13%
12:29

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
22.06.23
-
22.06.24
-
07.01.23

StockNews.com 
22.06.23 50%
sell
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€2.00
22.06.23
-
22.06.24
-21.30%
07.05.24

StockNews.com 
22.06.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
22.06.23
-
22.06.24
-
23.09.22

StockNews.com 
22.06.23 50%
sell
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.51
22.06.23
-
22.06.24
-17.65%
21.03.24

StockNews.com 
22.06.23 50%
sell
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€2.00
22.06.23
-
22.06.24
-21.30%
07.05.24

StockNews.com 
22.06.23 50%
sell
Oragenics Inc.

Start price
Target price
Perf. (%)
€7.60
21.06.23
-
21.06.24
0.00%
09.02.24

StockNews.com 
21.06.23 50%
sell
Avinger Inc.

Start price
Target price
Perf. (%)
€0.54
19.06.23
-
19.06.24
-32.96%
20.11.23

StockNews.com 
19.06.23 50%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€1.42
19.06.23
-
19.06.24
-71.55%
07.05.24

StockNews.com 
19.06.23 50%
sell
Oragenics Inc.

Start price
Target price
Perf. (%)
€7.60
19.06.23
-
19.06.24
0.00%
09.02.24

StockNews.com 
19.06.23 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
18.06.23
-
18.06.24
-
07.01.23

StockNews.com 
18.06.23 50%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
18.06.23
-
18.06.24
-
23.09.22

StockNews.com 
18.06.23 50%
sell
Oragenics Inc.

Start price
Target price
Perf. (%)
€7.60
17.06.23
-
17.06.24
0.00%
09.02.24

StockNews.com 
17.06.23 50%
sell
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.85
17.06.23
-
17.06.24
65.41%
07.05.24

StockNews.com 
17.06.23 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.67
17.06.23
-
17.06.24
-67.36%
15.12.23

StockNews.com 
17.06.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
17.06.23
-
17.06.24
-
23.12.22

StockNews.com 
17.06.23 50%